Molecular Matrix Brings ‘Next Generation’ Bone Regenerative Technology to the Market (press release) SMolecular Matrix, Inc. (“MMI”), is a California based company, that was incorporated in August 2011. MMI has developed an innovative new generation platform tissue regeneration for musculoskeletal applications, specifically bone, based on a novel hyper-crosslinked carbohydrate polymer (HCCP) scaffold technology. The HCCP technology provides an excellent environment for bone cells to grow, mature, and function.
MMI’s first product release, Osteo-PTM BGS, is a non- mineralized bone graft substitute intended for use in a multitude of different applications and treatments, such as filling defects in orthopedic surgery. When placed in direct contact with host bone, Osteo-PTM BGS supports and guides the ingrowth of new bone across the graft site and resorbs as the healing process occurs. The consistency of Osteo-PTM BGS allows the surgeon to easily manipulate and maximize the direct contact with viable host bone. It is highly porous, biocompatible, biodegradable and osteoconductive. MMI’s polymer technology also eliminates the inherent disadvantages associated with curr...
